"Therapeutic intent" in phase 1 oncology trials: a justifiable objective.
Markman
Maurie
M
The University of Texas M. D. Anderson Cancer Center, Mail Box 121, 1515 Holcombe Blvd, Houston, TX 77030, USA. mmarkman@mdanderson.org
D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D017321:Clinical Trials, Phase I as Topic; D004305:Dose-Response Relationship, Drug; D006801:Humans; D008495:Medical Oncology / Q000379:methods*; D009369:Neoplasms / Q000188:drug therapy*; D016896:Treatment Outcome
D000970:Antineoplastic Agents